AARS2 | Alanyl-tRNA synthetase 2, mitochondrial | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ABL1 | C-abl oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | | Tissue enriched |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | | Expressed in all |
AMPH | Amphiphysin | Cancer-related genes
| | | | | Tissue enriched |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BARD1 | BRCA1 associated RING domain 1 | Cancer-related genes Plasma proteins
| | | | | Mixed |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CCAR1 | Cell division cycle and apoptosis regulator 1 | Cancer-related genes
| | | | | Expressed in all |
CDC73 | Cell division cycle 73 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
CDH1 | Cadherin 1, type 1, E-cadherin (epithelial) | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CDK12 | Cyclin-dependent kinase 12 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CIC | Capicua transcriptional repressor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
CLTC | Clathrin, heavy chain (Hc) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CSDE1 | Cold shock domain containing E1, RNA-binding | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CTCF | CCCTC-binding factor (zinc finger protein) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CTNND1 | Catenin (cadherin-associated protein), delta 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CUL1 | Cullin 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DHX9 | DEAH (Asp-Glu-Ala-His) box helicase 9 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EWSR1 | EWS RNA-binding protein 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
GTF2H1 | General transcription factor IIH, polypeptide 1, 62kDa | Cancer-related genes
| | | | | Expressed in all |
HSP90AB1 | Heat shock protein 90kDa alpha (cytosolic), class B member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
LPP | LIM domain containing preferred translocation partner in lipoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MDC1 | Mediator of DNA-damage checkpoint 1 | Cancer-related genes
| | | | | Expressed in all |
MECOM | MDS1 and EVI1 complex locus | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
MED12 | Mediator complex subunit 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |